Matches in Wikidata for { <http://www.wikidata.org/entity/Q65339641> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q65339641 description "clinical trial" @default.
- Q65339641 description "ensayu clínicu" @default.
- Q65339641 description "klinisch onderzoek" @default.
- Q65339641 description "клінічне випробування" @default.
- Q65339641 name "Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin" @default.
- Q65339641 name "Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C" @default.
- Q65339641 type Item @default.
- Q65339641 label "Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin" @default.
- Q65339641 label "Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C" @default.
- Q65339641 prefLabel "Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin" @default.
- Q65339641 prefLabel "Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C" @default.
- Q65339641 P1050 Q65339641-151CF3FA-04DA-4D40-B204-460BE7B2C961 @default.
- Q65339641 P1050 Q65339641-23150CA6-17D5-4F23-904D-120F32517B89 @default.
- Q65339641 P1050 Q65339641-7707DEE6-728D-48D6-8FE3-C120C9F4771F @default.
- Q65339641 P1132 Q65339641-5855A468-D2A4-4B4E-9A28-0ED975CB2ACB @default.
- Q65339641 P131 Q65339641-56A9FFD2-0672-4B94-BA8B-C35FD780F528 @default.
- Q65339641 P1476 Q65339641-5FBC205B-C4A0-4B81-8934-50800BB2A18C @default.
- Q65339641 P17 Q65339641-B9C07C54-BDA5-4747-8D5C-526E9C3C0DDE @default.
- Q65339641 P3098 Q65339641-2F63FF0D-4184-4C81-A6C9-BDC6088F7D6A @default.
- Q65339641 P31 Q65339641-6F8D0F7E-3228-4EB6-BD39-5BC9080D9D13 @default.
- Q65339641 P4844 Q65339641-B152752F-8E64-44D4-97A3-D79944270C17 @default.
- Q65339641 P580 Q65339641-D21664A8-4AA7-4BE4-A4B2-CB6FD523BD21 @default.
- Q65339641 P582 Q65339641-DFE06C2D-6FC9-4A2E-A7B8-CDF391F0620C @default.
- Q65339641 P8363 Q65339641-5634A408-595E-419F-A5D5-21FC1FCB66FD @default.
- Q65339641 P859 Q65339641-95139980-8A3F-4B37-B8C3-FF8F13AF824F @default.
- Q65339641 P1050 Q131742 @default.
- Q65339641 P1050 Q154869 @default.
- Q65339641 P1050 Q157661 @default.
- Q65339641 P1132 "+10" @default.
- Q65339641 P131 Q1183 @default.
- Q65339641 P1476 "Long-Term Extension to a Phase 2, Open-Label, Clinical Trial of Miravirsen Sodium in Null Responders to Pegylated-Interferon Alpha Plus Ribavirin in Subjects With Chronic Hepatitis C (CHC) Virus Genotype 1 Infection" @default.
- Q65339641 P17 Q30 @default.
- Q65339641 P3098 "NCT02508090" @default.
- Q65339641 P31 Q30612 @default.
- Q65339641 P4844 Q20817235 @default.
- Q65339641 P580 "2013-08-02T00:00:00Z" @default.
- Q65339641 P582 "2017-01-13T00:00:00Z" @default.
- Q65339641 P8363 Q818574 @default.
- Q65339641 P859 Q212646 @default.